The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 01, 2014
Filed:
Aug. 08, 2011
Seung Ho Kim, Seoul, KR;
Ji Han Kim, Seoul, KR;
Je Hak Kim, Anyang-si, KR;
Kyung Wan Nam, Gunpo-si, KR;
Yong Ha Chi, Yongin-si, KR;
Joo Han Lee, Seoul, KR;
Soo Heui Paik, Ansan-si, KR;
SO Jeong Yi, Seoul, KR;
Tae Eun Kim, Seoul, KR;
Seo Hyun Yoon, Seoul, KR;
Joo Youn Cho, Seoul, KR;
Sang Goo Shin, Seoul, KR;
IN Jin Jang, Seoul, KR;
Kyung Sang Yu, Seoul, KR;
Seung Ho Kim, Seoul, KR;
Ji Han Kim, Seoul, KR;
Je Hak Kim, Anyang-si, KR;
Kyung Wan Nam, Gunpo-si, KR;
Yong Ha Chi, Yongin-si, KR;
Joo Han Lee, Seoul, KR;
Soo Heui Paik, Ansan-si, KR;
So Jeong Yi, Seoul, KR;
Tae Eun Kim, Seoul, KR;
Seo Hyun Yoon, Seoul, KR;
Joo Youn Cho, Seoul, KR;
Sang Goo Shin, Seoul, KR;
In Jin Jang, Seoul, KR;
Kyung Sang Yu, Seoul, KR;
Boryung Pharmaceutical Co., Ltd., Seoul, KR;
Abstract
Provided is an antihypertensive pharmaceutical composition containing Fimasartan, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as an angiotensin II receptor blocker, and Amlodipine, an isomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as a calcium channel blocker.